{"TopicDetails": {"type": 0, "ccm2Id": 31087407, "cftId": 0, "identifier": "IMI2-2017-12-07", "title": "European Screening Centre: unique library for attractive biology (ESCulab)", "publicationDateLong": 1500422400000, "callIdentifier": "H2020-JTI-IMI2-2017-12-two-stage", "callTitle": "H2020-JTI-IMI2-2017-12-two-stage", "callccm2Id": 31084814, "allowPartnerSearch": true, "workProgrammepart": {"id": 263550, "ccm_id": 31087848, "wp_part": "H2020-JTI-IMI-2017", "wp_year": "H2020-JTI-IMI-2017", "wp_title": "IMI2 Work Plan 2017", "wp_website": "http://www.imi.europa.eu/", "wp_document": "http://ec.europa.eu/research/participants/data/ref/h2020/other/wp/jtis/h2020-wp17-imi_en.pdf"}, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31062059, "abbreviation": "EU.3.1.7.", "description": "Innovative Medicines Initiative 2 (IMI2)"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}], "topicMGAs": [], "tags": ["IMI2", "Innovative Medicines Initiative", "attractive biology", "IMI", "Pharmacology", "drug therapy", "pharmacogenomics", "Drug discovery", "High throughput screening", "European Screening Centre", "IMI2 JU"], "keywords": ["Pharmacology, pharmacogenomics, drug discovery and"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "IMI2-RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "19 July 2017", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["24 October 2017", "16 May 2018"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3245023": [{"action": "IMI2-2017-12-03 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "19 July 2017", "deadlineModel": "two-stage", "deadlineDates": ["24 October 2017", "16 May 2018"], "budgetYearMap": {"2017": 126439000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2017-12-04 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "19 July 2017", "deadlineModel": "two-stage", "deadlineDates": ["24 October 2017", "16 May 2018"], "budgetYearMap": {"2017": 126439000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2017-12-05 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "19 July 2017", "deadlineModel": "two-stage", "deadlineDates": ["24 October 2017", "16 May 2018"], "budgetYearMap": {"2017": 126439000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2017-12-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "19 July 2017", "deadlineModel": "two-stage", "deadlineDates": ["24 October 2017", "16 May 2018"], "budgetYearMap": {"2017": 126439000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2017-12-02 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "19 July 2017", "deadlineModel": "two-stage", "deadlineDates": ["24 October 2017", "16 May 2018"], "budgetYearMap": {"2017": 126439000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2017-12-06 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "19 July 2017", "deadlineModel": "two-stage", "deadlineDates": ["24 October 2017", "16 May 2018"], "budgetYearMap": {"2017": 126439000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2017-12-07 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "19 July 2017", "deadlineModel": "two-stage", "deadlineDates": ["24 October 2017", "16 May 2018"], "budgetYearMap": {"2017": 126439000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2017"]}, "description": "<SPAN class=\"topicdescriptionkind\">Specific Challenge</SPAN>:<p>The translation of novel biological concepts into drug discovery projects critically requires chemical matter that has the potential to become a valuable tool in the treatment of a disease. One of the key barriers to this translation is access to high-quality compound libraries and high throughput screening facilities, especially to academic groups and SMEs</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>The project should include:</p><p><strong>A screening library. </strong>The core of the ESCulab library will ideally consist of ~550 000 unique, non-commercial compounds from the pharmaceutical companies and the short proposal applicant consortium. </p><p><strong>Compound logistics and uHTS screening facilities</strong></p><p><strong>Assay development capabilities</strong></p><p><strong>Screening facilities.</strong> ESCulab is expected to run 50 programmes free to the public and also develop a strategy to enable the screening of externally-funded screens </p><p><strong>Hit Confirmation capabilites </strong></p><p><strong>Long-term sustainability plans</strong></p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>Lower the hurdles for academic groups and SMEs to translate early innovative biology into chemical series that have the potential to be optimised into drug candidates</p><p>Cut timelines to arrive at clinical proof of concept in diseases with unmet medical need</p><p>Demonstrate that target owners have the confidence to further invest in the hit lists generated during the project</p><p>Sustainable, well recognised screening centre with access to a high-quality library which adopts a business model relying on externally funded screens.</p><p>ESCulab should be the operational partner of choice for scientists to bring modulation of their targets with small molecules from theory into practice.</p>\n", "conditions": "<p>Please read carefully all provisions below before the preparation of your application.</p>\r\n<p>The <strong>IMI2 12th Call for proposals topic text&nbsp;</strong>as well as the <strong>Call Conditions</strong> are available <strong><a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche17-12-imi2-ju_en.pdf\" target=\"_blank\">here</a></strong></p>\r\n<p><span style=\"color: rgb(0, 128, 128);\"><strong>1.\tList of countries and applicable rules for funding</strong></span>: described in article 10(2) of Regulation N&deg; 1290/2013 of 11 December 2013 laying down the rules for participation and dissemination in Horizon 2020 and in article 1 of the Commission Delegated Regulation (EU) N&deg; 622/2014 of 14 February 2014.<br />\r\n<br />\r\n<span style=\"color: rgb(0, 128, 128);\"><strong>2.\tEligibility and admissibility conditions: </strong></span>described in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju-v1.5_en.pdf\" target=\"_blank\"><strong>IMI2 Manual for evaluation, submission and grant award</strong></a>  See also the Commission Delegated Regulation (EU) N&deg; 622/2014 of 14 February 2014.</p>\r\n<p>Proposal page limits and layout: Please refer to Part B of the standard proposal template.<br />\r\n<br />\r\n<span style=\"color: rgb(0, 128, 128);\"><strong>3.\tEvaluation</strong></span><br />\r\n<br />\r\nSubmission and evaluation process, including evaluation criteria and procedure, scoring and threshold are described in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju-v1.5_en.pdf\" target=\"_blank\"><strong>IMI2 Manual for submission, evaluation and grant award</strong>.</a> See also the proposal templates for your specific action in section 5, below.<br />\r\n<br />\r\n<span style=\"color: rgb(0, 128, 128);\"><strong>4.\tIndicative timetable for evaluation and grant agreement:</strong></span><br />\r\n<br />\r\nNotification of outcomes of stage 1 evaluations: Maximum 5 months from deadline for submitting proposals.<br />\r\nNotification of outcomes of stage 2 evaluations: Maximum 5 months from deadline for submitting full proposals.</p>\r\n<p>Signature of grant agreements: maximum 3 months from the date of informing successful applicants.<br />\r\n<br />\r\n<span style=\"color: rgb(0, 128, 128);\"><strong>5.\tProvisions, proposal templates and evaluation forms:</strong></span></p>\r\n<p><u><strong>IMI2 Research and Innovation Action (IMI2-RIA) and (IMI2-IA):</strong></u></p>\r\n<p>Proposal templates are available after entering the submission tool<br />\r\n<br />\r\n<a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/ef/h2020-call-ef-imi2-ria-ia-2016_en.pdf\" target=\"_blank\">Standard evaluation form&nbsp;</a></p>\r\n<p><a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/mga/jtis/h2020-mga-imi_en.pdf\" target=\"_blank\">IMI2 Model Grant Agreement</a></p>\r\n<p><a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/legal/templ/h2020_tmpl-clinical-studies_en.pdf\" target=\"_blank\">Clinical trial template</a>&nbsp;&ndash; the Clinical Trial template is compulsory at stage 2 only !<br />\r\n<br />\r\n<span style=\"color: rgb(0, 128, 128);\"><strong>6.\tAdditional provisions:</strong></span><br />\r\nOpen access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.</p>\r\n<p>This topic participates per default in the open access to research data pilot which aims to improve and maximise access to and re-use of research data generated by projects:</p>\r\n<p>- The pilot applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available for open access and need to describe their approach in a Data Management   Plan (to be provided within six months after the project start).</p>\r\n<p>- Note that the evaluation phase proposals will not be evaluated more favourably because they are part of the Pilot, and will not be penalised for opting out of the Pilot.</p>\r\n<p>- Projects can at any stage opt-out of the pilot.</p>\r\n<p>The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.<br />\r\nFurther information on the Open Research Data Pilot is made available in the H2020 Online Manual: <a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/open-access-dissemination_en.htm\" target=\"_blank\">http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/open-access-dissemination_en.htm</a>&nbsp;<br />\r\n<br />\r\n<span style=\"color: rgb(0, 128, 128);\"><strong>7.\tAdditional documents:<br />\r\n</strong></span><br />\r\n<a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-rel-prov-imi-ju_en.pdf \" target=\"_blank\">Summary of the most relevant provisions for participating in IMI2 actions</a></p>\r\n<p><a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/Governance/AWP2017_%20v11July.pdf\" target=\"_blank\">IMI2 Annual Work Plan 2017&nbsp;</a><br />\r\n<br />\r\n<a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/RegulatoryRequirementsGuide.pdf\" target=\"_blank\">IMI2 Regulators Guidance tool for researchers&nbsp;</a></p>\r\n<p><a href=\"http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:JOL_2014_174_R_0003\" target=\"_blank\">IMI JU derogation to H2020 Rules for Participation</a> &nbsp;<br />\r\n<br />\r\n<a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/legal_basis/rules_participation/h2020-rules-participation_en.pdf\" target=\"_blank\">Horizon 2020 Rules for Participation&nbsp;</a></p>\r\n<p><a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/legal_basis/fp/h2020-eu-establact_en.pdf \" target=\"_blank\">Horizon 2020 Regulation of Establishment </a><br />\r\n<br />\r\n<a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/legal_basis/sp/h2020-sp_en.pdf\" target=\"_blank\">Horizon 2020 Specific Programme</a>&nbsp;</p>\r\n<p>&nbsp;</p>", "supportInfo": "<p><strong><a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/index_en.htm\">H2020 Online Manual</a></strong> your online guide on the procedures from proposal submission to managing your grant.<br />\r\n<br />\r\n<strong><span><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/support/faq.html\">Participant Portal FAQ</a> </span></strong><span>&ndash; Submission of proposals.</span></p>\r\n<p><strong><span><a href=\"mailto:applicants@imi.europa.eu ?subject=Information%20Request%20on%20IMI2%20Call%2012%20Topic%20xx\" target=\"_blank\">IMI2 JU Applicants Helpdesk</a></span></strong><span> &ndash; contact the IMI2 Programme Office for any question on the Call&nbsp;</span><br />\r\n<strong><br />\r\n<span><a href=\"http://ec.europa.eu/research/participants/portal4/desktop/en/support/national_contact_points.html\">National Contact Points (NCP)</a>&nbsp;&ndash;&nbsp;</span></strong><span>contact your NCP for further assistance.</span><br />\r\n<strong><br />\r\n<span><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\">Research Enquiry Service</a></span></strong><span> &ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span><br />\r\n<a href=\"http://een.ec.europa.eu/\"><br />\r\n<strong>Enterprise Europe Network</strong></a> &ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<br />\r\n<a href=\"http://ec.europa.eu/research/participants/api/contact/index.html\"><br />\r\n<strong>IT Helpdesk</strong></a>&nbsp;&ndash; contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</p>\r\n<p>Contact the EIT for further assistance related to the call, topics and the content of proposals via the <strong><a href=\"http://eit.europa.eu/interact/contact-us\">Contact Page on the EIT website</a></strong>.<br />\r\n<a href=\"http://www.imi.europa.eu/content/states-representatives-groups\"><br />\r\n<strong>IMI States Representative Group (SRG)</strong></a> &ndash; contact you SRG member for assistance.<br />\r\n<strong><br />\r\nEthics</strong> &ndash; for compliance with ethical issues, see the<a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\"> Participant Portal</a>&nbsp;and&nbsp;<a href=\"http://ec.europa.eu/research/swafs/index.cfm?pg=policy&amp;lib=ethics\">Science and Society Portal</a><br />\r\n<a href=\"http://www.iprhelpdesk.eu/\"><br />\r\n<strong>European IPR Helpdesk</strong></a> assists you on intellectual property issues<br />\r\n<a href=\"http://www.cen.eu/cen/Services/Innovation/Pages/default.aspx\"><br />\r\n<strong>CEN</strong></a> and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\"><strong>CENELEC</strong></a>, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\">research@cencenelec.eu</a>.<br />\r\n<a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\"><br />\r\n<strong>The European Charter for Researchers and the Code of Conduct for their recruitment</strong></a><br />\r\n<strong><br />\r\n<a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/grants/applying-for-funding/find-partners_en.htm\">Partner Search Services</a></strong> help you find a partner organisation for your proposal<br />\r\n<a href=\"http://www.imi.europa.eu/content/partner-search\"><br />\r\n<strong>IMI Partner Search Tool</strong></a> helps you find a partner organisation for your proposal</p>", "sepTemplate": "<p>To access the Electronic Submission Service of the topic, please select the <strong>type of action</strong> that is most relevant to your proposal from the list below and click on the <strong>'Start Submission' </strong>button. You will then be asked to confirm your choice of the type of action and topic, as these cannot be changed in the submission system. Upon confirmation you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Participant Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [{"callId": 52392575549, "id": 165852788, "title": "Call Flash Info Report", "sectionId": 52392575549, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 89754, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2017-12-07/1807625-imi2_call_12_-_falsh_call_info_-_stage_1_en.pdf", "id": 1807625, "fileName": "IMI2 Call 12 - Falsh Call Info - stage 1_EN.pdf", "common": false, "crc32": 3014507775}]}, {"callId": 52392575549, "id": 165852789, "title": "IMI2 Call 12 stage 2 - Flash Call Info Report ", "sectionId": 52392575549, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 89764, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2017-12-07/1827632-imi2_call_12_-_falsh_call_info_-_stage_2_en.pdf", "id": 1827632, "fileName": "IMI2 Call 12 - Falsh Call Info - stage 2_EN.pdf", "common": false, "crc32": 664110487}]}], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Jul 13, 2018 10:27:15 AM", "lastChangeDate": "Jul 13, 2018 10:27:15 AM", "content": "<p><font face=\"Arial, sans-serif\"><span style=\"font-size: 13.3333px;\"><b>An overview of the evaluation results (<a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2017-12-01/1827632-imi2_call_12_-_falsh_call_info_-_stage_2_en.pdf\" target=\"_blank\">Flash call info-IMI2 Call 12-stage two</a>) is now available under the call &lsquo;Additional documents&rsquo; tab.</b></span></font></p>"}, {"approvalDate": "Feb 26, 2018 3:26:16 PM", "lastChangeDate": "Feb 26, 2018 3:26:16 PM", "content": "<p>&nbsp;</p>\r\n<p class=\"MsoNormal\"><font face=\"Arial, sans-serif\"><span style=\"font-size: 13.3333px;\"><b>An overview of the evaluation results (<a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2017-12-01/1807625-imi2_call_12_-_falsh_call_info_-_stage_1_en.pdf\" target=\"_blank\">Flash call info-IMI2 Call 12-stage one</a>) is now available under the call &lsquo;Additional documents&rsquo; tab.</b></span></font></p>\r\n<p class=\"MsoNormal\"><span style=\"font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif\"><o:p>&nbsp;</o:p></span></p>\r\n<p>&nbsp;</p>"}, {"approvalDate": "Oct 26, 2017 5:24:38 PM", "lastChangeDate": "Oct 26, 2017 5:24:38 PM", "content": "<p><span lang=\"EN-IE\">A total number of 29 proposals were submitted in response to the IMI2 Call 12 - stage one. The number of proposals for each topic is shown below.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"FR-BE\">IMI2-2017-12-01: 8<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"FR-BE\">IMI2-2017-12-02: 2<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"FR-BE\">IMI2-2017-12-03: 1<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"FR-BE\">IMI2-2017-12-04: 7<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"FR-BE\">IMI2-2017-12-05: 4<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-IE\">IMI2-2017-12-06: 5<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-IE\">IMI2-2017-12-07: 2<o:p></o:p></span></p>"}, {"approvalDate": "Jul 19, 2017 11:47:00 AM", "lastChangeDate": "Jul 19, 2017 11:47:00 AM", "content": "The submission session is now available for: IMI2-2017-12-05(IMI2-RIA), IMI2-2017-12-01(IMI2-RIA), IMI2-2017-12-02(IMI2-RIA), IMI2-2017-12-06(IMI2-RIA), IMI2-2017-12-07(IMI2-RIA), IMI2-2017-12-04(IMI2-RIA), IMI2-2017-12-03(IMI2-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}